RFK Jr. unveils campaign for ‘deprescribing’ antidepressants

May 5, 2026 - 17:31

Health and Human Services Secretary Robert F. Kennedy Jr. announced a new campaign on Monday aimed at encouraging the reduction or elimination of antidepressant use among Americans. Speaking at a MAHA Institute summit, Kennedy outlined his vision for a federal push toward what he called "deprescribing" psychiatric medications.

The initiative, which Kennedy described as a top priority for his tenure, seeks to challenge what he views as an overreliance on pharmaceutical solutions for mental health. He argued that many patients are kept on antidepressants for years without proper oversight or exploration of alternative treatments, such as diet, exercise, and therapy. Kennedy cited rising rates of prescription drug use and questioned the long-term safety and efficacy of these medications for mild to moderate depression.

Critics quickly pushed back, warning that a government-led campaign to stop taking prescribed medications could be dangerous. Mental health professionals emphasized that antidepressants are life-saving for many individuals with severe depression or anxiety disorders. They cautioned against broad, non-clinical recommendations that might lead patients to quit their medication abruptly, risking withdrawal symptoms or relapse.

Kennedy's plan includes funding for research into non-pharmaceutical interventions and the creation of federal guidelines for tapering off medication under medical supervision. The announcement has reignited a national debate over the role of government in personal healthcare decisions and the balance between pharmaceutical regulation and patient autonomy.